Biohaven (BHVN) Net Equity Issued and Repurchased (2023 - 2026)

Biohaven (BHVN) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $178.9 million in Q1 2026.

• For the quarter ending Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $178.9 million; the trailing twelve-month figure through Mar 2026 stood at $368.1 million (down 37.71% YoY), and the FY2025 full-year result was $189.2 million, down 71.6% from the prior year.
• Net Equity Issued and Repurchased retreated to $178.9 million in Q1 2026, from $189.2 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $271.3 million in Q4 2024 to a low of $76.4 million in Q3 2024.
• A 4-year average of $191.8 million and a median of $189.2 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
• Across the five-year window, Net Equity Issued and Repurchased gained 11.54% in 2024 and slumped 30.27% in 2025, its largest moves.
• Tracing BHVN's Net Equity Issued and Repurchased over 4 years: stood at $243.2 million in 2023, then advanced by 11.54% to $271.3 million in 2024, then tumbled by 30.27% to $189.2 million in 2025, then decreased by 5.44% to $178.9 million in 2026.
• Business Quant data shows BHVN's Net Equity Issued and Repurchased at $178.9 million in Q1 2026, $189.2 million in Q4 2025, and $271.3 million in Q4 2024.